. 2020 May 13;8:e9090. doi: 10.7717/peerj.9090

Table 1. Clinical characteristics of participants with electrocardiogram and non-specific ST-T segment changes.

	Normal	Non-specific ST-T segment changes	Chi-square	P-value
	n (%) or median (quartile)	n (%) or median (quartile)
Sex			108.506	<0.001
Female (n)	14701 (46.7)	872 (60.7)
Male (n)	16785 (53.3)	564 (39.3)
Age (years)	41.0 (32.0–49.0)	50.0 (42.0–57.0)	−26.345	<0.001
Height (cm)	167.0 (160.0–171.5)	163.5 (157.5–170.5)	−11.856	<0.001
Weight (kg)	64.5 (56.0–73.8)	65.4 (57.2–75.5)	−3.862	<0.001
BMI (kg/m²)	23.4 (21.2–25.7)	24.7 (22.4–27.1)	−13.733	<0.001
Heart rate (bpm)	74.0 (69.0–80.0)	74.0 (69.0–81.0)	−0.304	0.761
Systolic blood pressure (mmHg)	117.0 (106.0–128.0)	125.0 (110.0–140.0)	−18.430	<0.001
Diastolic blood pressure (mmHg)	75.0 (70.0–80.0)	80.0 (74.0–90.0)	−20.054	<0.001
Fasting plasma glucose (mmol/l)	4.9 (4.6–5.3)	5.1 (4.8–5.7)	−12.591	<0.001
Triglyceride (mmol/l)	1.2 (0.8–1.8)	1.4 (1.0–2.1)	−10.355	<0.001
AST (U/L)	21.0 (17.0–26.0)	22.0 (18.0–28.0)	−6.610	<0.001
ALT (U/L)	21.0 (15.0–32.0)	23.0 (16.0–35.0)	−4.651	<0.001
ALP (U/L)	68.0 (57.0–82.0)	73.0 (59.0–89.0)	−8.351	<0.001
GGT (U/L)	20.0 (14.0–33.0)	22.0 (15.3–38.0)	−5.967	<0.001
Total cholesterol (mmol/l)	4.8 (4.2–5.3)	5.1 (4.5–5.7)	−12.130	<0.001
HDL-C (mmol/l)	1.4 (1.3–1.6)	1.4 (1.3–1.7)	−2.848	0.004
LDL-C (mmol/l)	2.5 (2.1–3.1)	2.7 (2.2–3.3)	−8.615	<0.001
NAFLD severity on ultrasound (%)			148.115	<0.001
No steatosis	22648 (71.9)	820 (57.1)
Mild steatosis	7181 (22.8)	507 (35.3)
Moderate/severe steatosis	1657 (5.3)	109 (7.6)

Notes.

Sample size, n = 32922. Data are expressed as mean SD or median (quartile).